Menzl, Ingeborg http://orcid.org/0000-0003-3347-7772
Zhang, Tinghu
Berger-Becvar, Angelika
Grausenburger, Reinhard
Heller, Gerwin
Prchal-Murphy, Michaela
Edlinger, Leo
Knab, Vanessa M.
Uras, Iris Z.
Grundschober, Eva
Bauer, Karin
Roth, Mareike
Skucha, Anna
Liu, Yao
Hatcher, John M.
Liang, Yanke
Kwiatkowski, Nicholas P.
Fux, Daniela
Hoelbl-Kovacic, Andrea
Kubicek, Stefan http://orcid.org/0000-0003-0855-8343
Melo, Junia V.
Valent, Peter
Weichhart, Thomas http://orcid.org/0000-0002-4349-0797
Grebien, Florian http://orcid.org/0000-0003-4289-2281
Zuber, Johannes
Gray, Nathanael S. http://orcid.org/0000-0001-5354-7403
Sexl, Veronika
Funding for this research was provided by:
Austrian Science Fund (P27248-B28 to D.F., P28571-B21 to V.S., F4706-B20 to V.S., SFB6107 to V.S., F4704-B20 to P.V.)
Article History
Received: 12 January 2019
Accepted: 20 September 2019
First Online: 18 October 2019
Competing interests
: N.S.G. is a founder, science advisory board member (SAB), and equity holder in Gatekeeper, Syros, Petra, C4, B2S, and Soltego. The Gray lab receives or has received research funding from Novartis, Takeda, Astellas, Taiho, Janssen, Kinogen, Voronoi, Her2llc, Deerfield, and Sanofi. N.P.K., N.S.G., T.Z., and Y.L. are inventors on the patent WO2017/185034 that covers degrader YKL-06-101. N.S.G. and J.M.H. are inventors on a patent that covers JH-XI-10-02. The remaining authors declare no competing interests.